Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

KalVista Pharmaceuticals Presents Late-Breaking Phase 3 KONFIDENT Trial Data On Sebetralstat At EAACI Congress; NEJM Publication Highlights 9-Minute Median Time To Treatment And 1.3-Hour Symptom Relief For Laryngeal Attacks In KONFIDENT-S Trial

Author: Benzinga Newsdesk | May 31, 2024 12:17pm

Posted In: KALV